CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. - Wikidata - wikimedia - TriplyDB

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

http://www.wikidata.org/entity/Q35835717

about

Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients Cerebrospinal fluid biomarkers of Alzheimer’s disease Revolutionizing Alzheimer's disease and clinical trials through biomarkers Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics Psychosis in Alzheimer's disease VSNL1 Co-Expression Networks in Aging Include Calcium Signaling, Synaptic Plasticity, and Alzheimer's Disease Pathways Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.Genetics of Psychosis in Alzheimer Disease.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Emerging biomarkers in cognition.YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt Pathways.Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation.Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Progress update: fluid and imaging biomarkers in Alzheimer's disease.The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration.Serum visinin-like protein-1 in concussed professional ice hockey players.Disease modification and Neuroprotection in neurodegenerative disorders.Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease.A meta-analysis of cerebrospinal fluid visinin-like protein-1 in alzheimers disease patients relative to healthy controls and mild cognitive impairment patients.A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington's disease.CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.

P2860

Q21559700-F7DDB42A-8AAA-4A53-8F6A-5B6B264E4684 Q22252572-6D5F6368-3952-4EEA-9A7D-1CAA1144E76E Q26744882-A0809B2A-C2A8-4B21-B84E-9B9E5293B111 Q26784569-B5C59544-7A8F-4EFD-9E43-CE5A54FD1541 Q26824635-F6534BBB-95DE-4D94-9BB9-D5E74153B584 Q30416128-899BE5E6-CE75-4C75-8571-A0CF84F851B7 Q30845482-68527B5B-0F1B-4ABB-AD66-69FBD6E50881 Q33554802-5E0949A7-4F4F-4F56-9995-2A8EBB6499F2 Q33666458-37FFD8E0-58EF-4831-8ECD-D1F4CFFB569F Q33687554-2AB05B85-5CBC-4D2E-9B0F-1AD3A17707FE Q33769278-51D7284A-67E9-4DAB-AACA-EEFF46F90572 Q34548296-FCD8FAFA-620B-42E9-95A4-6C305B177078 Q34735454-06097712-9D58-44BA-9F1F-76FA3E1F8C72 Q35008258-CD2A24FC-1313-4831-9D4F-94C46F934A98 Q35148080-43898095-0E2B-4348-9B75-3BA14AEAA621 Q36001286-0BEDC480-F497-4391-B8FB-4E701E0EAE83 Q36062391-638AF379-8C37-4C1E-B280-987061C0B362 Q36071742-5F9F5474-0422-44E8-BAAF-0E9F678A7FFF Q36337525-FE0BB150-959E-4866-8755-1551C1F68A6A Q36545406-C74EB8B8-F623-4584-9744-9201DDD36394 Q36885492-97DD612B-DD41-46E6-A32B-7B0CD1368C7E Q36901561-7EF428F2-4597-4AA9-AF5F-1B94F58D989A Q37237233-604C517C-ECAD-4882-853E-A8ACB4314596 Q37241698-3AFCCD20-126D-49A1-A7A3-67F849BCD517 Q37258203-DACF2580-EAE7-44BE-90BD-C43A31929B0D Q37297626-DC9E1006-610A-4E34-90AB-A1AEF491ABC5 Q37626382-6618A15D-8C0D-4996-9865-A9E17981F898 Q38592265-0BD2D847-131C-4029-A0DB-7DBC2F55E7EA Q38693438-268834EC-C1D0-4527-B65D-AE1CC36BB436 Q38979999-FE023E19-9A8B-4447-9EFE-33AE62DB48ED Q39217840-780C8C91-01F8-4A37-9F63-B8163FC860C2 Q40032161-075F60EC-CB14-4119-8E4A-00E3D58EA131 Q40106280-9C3BA74C-FC68-45FE-BC94-C54779101D9C Q41752825-BC7E7F7D-7B0D-4741-B590-4A610990A1BE Q42363882-BD713E50-FC72-4EBE-8CD5-C9B14E9B795D Q42655670-54BD7207-6215-4737-AF3E-88FADCC2815A Q47141209-625CEC77-3CCB-45E7-84FB-2816B7C661C4 Q47250022-380BF491-7FA9-4B71-8C2B-CF73CEC6173C Q50531505-3F18D1EE-6F44-4F26-8E5C-EC33DD55E967 Q50879174-6520AD5E-6151-4E7A-AB00-A47616A82513

P2860

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

http://www.wikidata.org/entity/Q35835717

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@ast

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@en

type

label

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@ast

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@en

prefLabel

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@ast

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

@en

P1433

Q35835717-824F84B5-DB97-4A50-997D-A8CA2BF09ACA

P1476

Q35835717-25210C9C-B0BC-43D5-8AAF-0134576566EC

P2093

Q35835717-1C397233-76E3-480E-8196-922DE2C4F3FE

Q35835717-B596104A-2265-44B2-ABA4-07A26B1D16C9

Q35835717-B82DA576-8F4E-4A71-8238-25A128CB9571

Q35835717-F66D56EB-652C-4955-9D1F-5E9B130ABE6E

P2860

Q35835717-00E871D5-F8E3-4D07-A350-B4944DB73E2D

Q35835717-0329930C-6A61-4610-98FD-88FE4B32B2F6

Q35835717-0575B76A-6388-4E2E-B5AB-70BEBECC284C

Q35835717-0DE938A9-8A45-453C-B180-4BD93E65D21F

Q35835717-1B011EE7-5EB4-4F2C-AFF3-7076B2F5834F

Q35835717-4080DB37-EEC1-431F-A86B-2A604945AF3A

Q35835717-4277DBF2-2BB7-4CF0-A18B-11F79C719062

Q35835717-46722D3D-1C74-42F8-9183-307BF67D8DBA

Q35835717-46BF9ED7-469A-429D-A36A-698C424BE8E1

Q35835717-4795DDE1-8160-47D3-9A13-B2F596C08990

P304

Q35835717-AA9B9539-B437-4561-82C4-9B3E20FC095A

P31

Q35835717-F6DA8043-0B5A-4B6B-BBEF-5607DA557A32

P356

Q35835717-921BEC9B-CE1F-450C-B35F-048A48CE1EA7

P407

Q35835717-62F717F4-318F-4F3C-9995-24ABC3322651

P433

Q35835717-7CADB73F-F670-486C-8F20-F3BAF64410B9

P478

Q35835717-CE57D0A8-2663-4668-8892-312D1B893F91

P50

Q35835717-B13BC11E-E60C-42F9-9693-38E37EDCF4C9

P577

Q35835717-A08D8808-FCE4-4F52-9BBD-B9D2B8C45ADE

P698

Q35835717-D467CDCB-0D50-4443-998F-5B73B57C64A5

P921

Q35835717-B41F016A-8BFE-4A8D-B0E0-43C0091C0656

P932

Q35835717-E7426DA3-68EA-4EF8-B2DC-1D0BFEF37814

P356

WNL.0B013E318248E568

P1433

P1476

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease

@en

P2093

D M Holtzman

http://www.w3.org/2001/XMLSchema#string

J C Morris

http://www.w3.org/2001/XMLSchema#string

J H Ladenson

http://www.w3.org/2001/XMLSchema#string

R Tarawneh

http://www.w3.org/2001/XMLSchema#string

P2860

The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?

Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The Clinical Dementia Rating (CDR): current version and scoring rules

Semantic memory and the brain: structure and processes.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Episodic memory, amnesia, and the hippocampal-anterior thalamic axis.

Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease.

The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

P304

709-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E318248E568

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22357717

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3306162

http://www.w3.org/2001/XMLSchema#string